Welcome to LookChem.com Sign In|Join Free

CAS

  • or
AC-DL-PHG-OH, also known as Acetyl-DL-Phenylglycine, is a white powder chemical compound that serves as a crucial intermediate in the optical resolution of DL-phenylglycine. It is widely utilized in the pharmaceutical industry for the synthesis of various pharmaceuticals, particularly those involving chiral molecules.

15962-46-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 15962-46-6 Structure
  • Basic information

    1. Product Name: AC-DL-PHG-OH
    2. Synonyms: AC-DL-PHENYLGLYCINE;AC-DL-PHG-OH;ACETYL-DL-PHENYLGLYCINE;2-(ACETYLAMINO)-2-PHENYLACETIC ACID;N-ALPHA-ACETYL-DL-PHENYLGLYCINE;N-acetyl-dl-phenylglycine;(±)-(acetamido)phenylacetic acid;rac-(2R*)-2-(Acetylamino)-2-phenylacetic acid
    3. CAS NO:15962-46-6
    4. Molecular Formula: C10H11NO3
    5. Molecular Weight: 193.2
    6. EINECS: 240-098-4
    7. Product Categories: N/A
    8. Mol File: 15962-46-6.mol
  • Chemical Properties

    1. Melting Point: 197 °C
    2. Boiling Point: 439.2 °C at 760 mmHg
    3. Flash Point: 219.4 °C
    4. Appearance: White/Powder
    5. Density: 1.233 g/cm3
    6. Vapor Pressure: 1.73E-08mmHg at 25°C
    7. Refractive Index: 1.555
    8. Storage Temp.: Store at RT.
    9. Solubility: soluble in Methanol
    10. PKA: 3.17±0.10(Predicted)
    11. CAS DataBase Reference: AC-DL-PHG-OH(CAS DataBase Reference)
    12. NIST Chemistry Reference: AC-DL-PHG-OH(15962-46-6)
    13. EPA Substance Registry System: AC-DL-PHG-OH(15962-46-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 15962-46-6(Hazardous Substances Data)

15962-46-6 Usage

Uses

Used in Pharmaceutical Industry:
AC-DL-PHG-OH is used as an intermediate for the optical resolution of DL-phenylglycine, which is essential for the synthesis of various pharmaceuticals. The optical resolution process allows for the separation of enantiomers, which are crucial in the development of drugs with improved efficacy and reduced side effects.
Used in Chiral Synthesis:
AC-DL-PHG-OH is used as a chiral building block in the synthesis of enantiomerically pure compounds. The ability to produce single enantiomers is vital in the pharmaceutical industry, as the different enantiomers of a drug can have significantly different biological activities and side effects.
Used in Research and Development:
AC-DL-PHG-OH is also used in research and development for the study of chiral chemistry and the development of novel methods for the synthesis of enantiomerically pure compounds. This contributes to the advancement of pharmaceuticals with improved therapeutic properties and reduced side effects.

Check Digit Verification of cas no

The CAS Registry Mumber 15962-46-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,9,6 and 2 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 15962-46:
(7*1)+(6*5)+(5*9)+(4*6)+(3*2)+(2*4)+(1*6)=126
126 % 10 = 6
So 15962-46-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H11NO3/c1-7(12)11-9(10(13)14)8-5-3-2-4-6-8/h2-6,9H,1H3,(H,11,12)(H,13,14)

15962-46-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A2687)  N-Acetyl-DL-2-phenylglycine  >98.0%(HPLC)(T)

  • 15962-46-6

  • 5g

  • 360.00CNY

  • Detail
  • TCI America

  • (A2687)  N-Acetyl-DL-2-phenylglycine  >98.0%(HPLC)(T)

  • 15962-46-6

  • 25g

  • 990.00CNY

  • Detail

15962-46-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-acetamido-2-phenylacetic acid

1.2 Other means of identification

Product number -
Other names 2-(acetylamino)-2-phenylacetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15962-46-6 SDS

15962-46-6Relevant articles and documents

GRANZYME B DIRECTED IMAGING AND THERAPY

-

Page/Page column 82; 105, (2019/09/04)

Provided herein are heterocyclic compounds useful for imaging Granzyme B. Methods of imaging Granzyme B, combination therapies, and kits comprising the Granzyme B imaging agents are also provided.

Chemo- and Enantioselective Pd/B Hybrid Catalysis for the Construction of Acyclic Quaternary Carbons: Migratory Allylation of O-Allyl Esters to α- C-Allyl Carboxylic Acids

Fujita, Taiki,Yamamoto, Tomohiro,Morita, Yuya,Chen, Hongyu,Shimizu, Yohei,Kanai, Motomu

supporting information, p. 5899 - 5903 (2018/05/14)

We describe herein the asymmetric synthesis of α-allyl carboxylic acids containing an α-quaternary stereocenter by a chiral hybrid catalyst system comprising palladium and boron complexes. The reaction proceeded through palladium-catalyzed ionization of α,α-disubstituted O-allyl esters for the generation of chiral π-allyl palladium complex as an electrophile, boron-catalyzed enolization of the carboxylate part for the generation of chiral α,α-disubstituted carboxylic acid-derived enolates as a nucleophile, and enantioselective coupling between the thus-generated nucleophile and electrophile. Proper combinations of chiral ligands for the boron and palladium catalysts were crucial. The reaction proceeded chemoselectively at the α-position of the carboxylic acid group.

Regiodivergent Enantioselective γ-Additions of Oxazolones to 2,3-Butadienoates Catalyzed by Phosphines: Synthesis of α,α-Disubstituted α-Amino Acids and N,O-Acetal Derivatives

Wang, Tianli,Yu, Zhaoyuan,Hoon, Ding Long,Phee, Claire Yan,Lan, Yu,Lu, Yixin

supporting information, p. 265 - 271 (2016/01/25)

Phosphine-catalyzed regiodivergent enantioselective C-2- and C-4-selective γ-additions of oxazolones to 2,3-butadienoates have been developed. The C-4-selective γ-addition of oxazolones occurred in a highly enantioselective manner when 2-aryl-4-alkyloxazol-5-(4H)-ones were employed as pronucleophiles. With the employment of 2-alkyl-4-aryloxazol-5-(4H)-ones as the donor, C-2-selective γ-addition of oxazolones took place in a highly enantioselective manner. The C-4-selective adducts provided rapid access to optically enriched α,α-disubstituted α-amino acid derivatives, and the C-2-selective products led to facile synthesis of chiral N,O-acetals and γ-lactols. Theoretical studies via DFT calculations suggested that the origin of the observed regioselectivity was due to the distortion energy that resulted from the interaction between the nucleophilic oxazolide and the electrophilic phosphonium intermediate.

Chemical resolution of DL-phenylalanine methyl ester using N-acetyl-D-phenylglycine as resolving agent

Wang, Shuai-Shuai,Zou, Fang,Meng, Wen-Qi,Zhang, Jing-Zheng,Feng, Yan,Zhang, Ling,Liu, Yi

, p. 159 - 161 (2015/06/02)

An improved method for chemical resolution of DL-phenylalanine methyl ester using N-acetyl-D-phenylglycine as a resolving agent is described. This new resolving agent is readily available, non-toxic and easily recoverable from the insoluble diasteromeric salt. This method was used to obtain D-phenylalanine methyl ester with high optical purity of 98.1% and a high yield of 81.2%.

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 99, (2012/02/15)

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists

Cilibrizzi, Agostino,Schepetkin, Igor A.,Bartolucci, Gianluca,Crocetti, Letizia,Dal Piaz, Vittorio,Giovannoni, Maria Paola,Graziano, Alessia,Kirpotina, Liliya N.,Quinn, Mark T.,Vergelli, Claudia

experimental part, p. 3781 - 3792 (2012/08/28)

A series of chiral pyridazin-3(2H)-ones was synthesized, separated as pure enantiomers, and evaluated for N-formyl peptide receptor (FPR) agonist activity. Characterization of the purified enantiomers using combined chiral HPLC and chiroptical studies (circular dichroism, allowed unambiguous assignment of the absolute configuration for each pair of enantiomers). Evaluation of the ability of racemic mixtures and purified enantiomers to stimulate intracellular Ca 2+ flux in FPR-transfected HL-60 cells and human neutrophils and to induce β-arrestin recruitment in FPR-transfected CHO-K1 cells showed that many enantiomers were potent agonists, inducing responses in the sub-micromolar to nanomolar range. Furthermore, FPRs exhibited enantiomer selectivity, generally preferring the R-(-)-forms over the S-(+)-enantiomers. Finally, we found that elongation of the carbon chain in the chiral center of the active compounds generally increased biological activity. Thus, these studies provide important new information regarding molecular features involved in FPR ligand preference and report the identification of a novel series of FPR agonists.

Convenient method for reduction of C-N double bonds in oximes, imines, and hydrazones using sodium Borohydride-Raney ni system

Yang, Yihua,Liu, Shouxin,Li, Junzhang,Tian, Xia,Zhen, Xiaoli,Han, Jianrong

, p. 2540 - 2554 (2012/07/27)

(Chemical Equation Presented) A practical method has been developed for reduction of C-N double bond in oximes, imines, and hydrazones with sodium borohydride catalyzed by Raney Ni. The reactions were carried out in basic aqueous solution, and the desired products were obtained in moderate yields after a simple procedure. This method can be applied to synthesize simpler aliphatic or aromatic amines and its analogs. Copyright Taylor & Francis Group, LLC.

Efficient kinetic resolution of amino acids catalyzed by lipase AS 'Amano' via cleavage of an amide bond

Wang, Bo,Liu, Yanfeng,Zhang, Dela,Feng, Yuhong,Li, Jiacheng

, p. 1338 - 1342,5 (2020/09/16)

Herein the efficient kinetic resolution of non-natural alpha-amino acids catalyzed by lipase AS 'Amano' via cleaving the amide bond is reported. The starting materials were the corresponding amino acid amides and the amino acids were generated with ees of up to 99% with E values of >600. These results indicated that the lipase AS 'Amano' could be a powerful amide hydrolase for the kinetic resolution of amino acid starting from the corresponding amino acid amides.

Preparation of cross-linked enzyme aggregates of l-aminoacylase via co-aggregation with polyethyleneimine

Vaidya, Bhalchandra K.,Kuwar, Suyog S.,Golegaonkar, Sandeep B.,Nene, Sanjay N.

experimental part, p. 184 - 191 (2012/03/22)

l-Aminoacylase from Aspergillus melleus was co-aggregated with polyethyleneimine and subsequently cross-linked with glutaraldehyde to obtain aminoacylase-polyethyleneimine cross-linked enzyme aggregates (termed as AP-CLEA). Under the optimum conditions, AP-CLEA expressed 74.9% activity recovery and 81.2% aggregation yield. The said method of co-aggregation and cross-linking significantly improved the catalytic stability of l-aminoacylase with respect to temperature and storage. AP-CLEA were employed for enantioselective synthesis of three unnatural amino acids (namely: phenylglycine, homophenylalanine and 2-naphthylalanine) via chiral resolution of their ester-, amide- and N-acetyl derivatives. The enantioselectivity of AP-CLEA was the highest for hydrolysis of amino acid amides; was moderate for hydrolysis of N-acetyl amino acids and was the least for hydrolysis of amino acid esters. Furthermore, AP-CLEA were found to retain more than 92% of the initial activity after five consecutive batches of (RS)-homophenylalanine hydrolysis suggesting an adequate operational stability of the biocatalyst.

HEPATITIS C VIRUS INHIBITORS

-

Page/Page column 134, (2011/07/30)

The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS5A protein

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15962-46-6